| Literature DB >> 31128607 |
Margaux Lepainteur1, Adam Ogna2, Bernard Clair2, Aurélien Dinh3, Catherine Tarragon2, Hélène Prigent2, Benjamin Davido3, Frédéric Barbot4, Isabelle Vaugier4, Muriel Afif5, Anne-Laure Roux6, Martin Rottman6, David Orlikowski7, Jean-Louis Herrmann6, Djillali Annane2, Christine Lawrence8.
Abstract
The aim of this study was to describe the endotracheal respiratory flora in a population of adults suffering from neuromuscular or neurological disorders requiring a long-term tracheostomy and to identify risk factors for colonization. We conducted a prospective and single-center observational study among patients with chronic tracheostomy admitted for planned respiratory assessment between February 2015 and December 2016. Data were collected from patient interview and medical charts with a standardized questionnaire. A tracheal aspiration was performed for each patient. Humidifiers were analysed for bacteriological contamination. Overall 77 tracheal aspirates (TA) were obtained from patients included. Pathogenic bacteria were found in 90% of cases (69/77) with a majority of Pseudomonas aeruginosa (32/77, 41%), Staphylococcus aureus (34/77, 44%) and Serratia marcesens. (22/79, 38%) Amoxicillin + Clavulanic-acid and Cefotaxime were adapted for respectively in only 28% and 35% of the subjects due to the natural resistance of organisms. No pathogenic bacteria were isolated from humidifier samples. Risk factors significantly associated with P. aeruginosa colonization were residence in a medical-care home (p = 0.01, OR = 3.8 [1.1; 15.1]) and the presence of a cuff (p = 0.003, OR = 4.4 [1.1; 20.6]). Significant quantities of pathogenic bacteria are frequently isolated from TA of tracheostomised patients in the absence of infection. The frequent resistance of these pathogens to Amoxicillin + Clavulanic-acid precludes the use of this antibiotic in the empiric treatment of pneumonia in this population.Entities:
Keywords: Chronic tracheostomised adults; Tracheal colonization
Mesh:
Substances:
Year: 2019 PMID: 31128607 DOI: 10.1016/j.rmed.2019.04.015
Source DB: PubMed Journal: Respir Med ISSN: 0954-6111 Impact factor: 3.415